Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / SHS
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
10,277,545
-
Shares change
-
-228,939
-
Total reported value, excl. options
-
$90,441,000
-
Value change
-
-$2,444,655
-
Number of buys
-
9
-
Number of sells
-
-11
-
Price
-
$8.80
Significant Holders of AC Immune SA - SHS (ACIU) as of Q2 2017
25 filings reported holding ACIU - AC Immune SA - SHS as of Q2 2017.
AC Immune SA - SHS (ACIU) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,277,545 shares
.
Largest 10 shareholders include FMR LLC (3,507,220 shares), Duquesne Family Office LLC (2,388,700 shares), Temasek Holdings (Private) Ltd (1,337,500 shares), PointState Capital LP (1,000,000 shares), Jefferies Group LLC (728,575 shares), Hillhouse Capital Management, Ltd. (550,000 shares), Artal Group S.A. (500,000 shares), CITADEL ADVISORS LLC (140,693 shares), COHEN LAWRENCE B (33,750 shares), and GEODE CAPITAL MANAGEMENT, LLC (25,953 shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.